Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,621,284
  • Shares Outstanding, K 43,057
  • Annual Sales, $ 2,877 M
  • Annual Income, $ 1,195 M
  • EBIT $ 1,494 M
  • EBITDA $ 1,566 M
  • 60-Month Beta 0.85
  • Price/Sales 7.38
  • Price/Cash Flow 17.00
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 43.54% (+0.81%)
  • Historical Volatility 19.59%
  • IV Percentile 77%
  • IV Rank 26.07%
  • IV High 92.62% on 08/25/25
  • IV Low 26.23% on 06/18/25
  • Expected Move (DTE 14) 23.80 (4.90%)
  • Put/Call Vol Ratio 0.30
  • Today's Volume 48
  • Volume Avg (30-Day) 518
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 28,289
  • Open Int (30-Day) 26,490
  • Expected Range 461.56 to 509.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 6.78
  • Number of Estimates 7
  • High Estimate 7.94
  • Low Estimate 5.79
  • Prior Year 6.19
  • Growth Rate Est. (year over year) +9.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
455.63 +6.53%
on 01/20/26
509.40 -4.72%
on 01/07/26
-17.35 (-3.45%)
since 01/06/26
3-Month
444.04 +9.31%
on 11/07/25
519.99 -6.66%
on 12/23/25
+31.36 (+6.91%)
since 11/06/25
52-Week
266.98 +81.80%
on 04/09/25
519.99 -6.66%
on 12/23/25
+131.61 (+37.20%)
since 02/06/25

Most Recent Stories

More News
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

UTHR : 485.36 (+1.34%)
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

UTHR : 485.36 (+1.34%)
United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure

This study was the world’s first FDA-cleared clinical trial using a bioengineered liver. Based on these positive results, United Therapeutics will initiate a phase 2 study ...

UTHR : 485.36 (+1.34%)
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that the company’s Board of Directors appointed Kevin J. Tracey, M.D., to...

UTHR : 485.36 (+1.34%)
3 Market-Beating Stocks to Target This Week

3 Market-Beating Stocks to Target This Week

KLAC : 1,442.95 (+8.41%)
SYF : 75.16 (+1.99%)
UTHR : 485.36 (+1.34%)
2 Cash-Heavy Stocks to Target This Week and 1 We Question

2 Cash-Heavy Stocks to Target This Week and 1 We Question

TCBI : 104.47 (+0.94%)
BRZE : 17.79 (+0.34%)
UTHR : 485.36 (+1.34%)
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Dr. Martine Rothblatt , Chairperson and Chief Executive Officer, will present a company overview and update...

UTHR : 485.36 (+1.34%)
2 Mooning Stocks on Our Buy List and 1 That Underwhelm

2 Mooning Stocks on Our Buy List and 1 That Underwhelm

CSCO : 84.82 (+2.99%)
UTHR : 485.36 (+1.34%)
HWM : 223.16 (+6.52%)
3 Market-Beating Stocks Worth Your Attention

3 Market-Beating Stocks Worth Your Attention

CECO : 72.37 (+6.33%)
RCL : 348.00 (+6.72%)
UTHR : 485.36 (+1.34%)
The Biotech Boom Gets a Trading Tool: How Direxion's Titans ETF Gives Access to the Sector's Top Performers

Amid the biotechnology sector's transformative era the Direxion Daily Biotech Top 5 Bull 2X ETF ($TBXU) offers traders a new, single-trade solution to gain 2X daily leveraged exposure to an e

ALNY : 328.16 (-0.93%)
EXEL : 43.90 (+3.61%)
GILD : 152.50 (+2.10%)
INSM : 149.86 (-0.77%)
UTHR : 485.36 (+1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 496.81
2nd Resistance Point 493.15
1st Resistance Point 489.26
Last Price 485.36
1st Support Level 481.71
2nd Support Level 478.05
3rd Support Level 474.16

See More

52-Week High 519.99
Last Price 485.36
Fibonacci 61.8% 423.34
Fibonacci 50% 393.48
Fibonacci 38.2% 363.63
52-Week Low 266.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar